Ann & Robert H Lurie Children's Hospital Of Chicago
Clinical trials sponsored by Ann & Robert H Lurie Children's Hospital Of Chicago, explained in plain language.
-
New program aims to break down barriers to ADHD care for children
Disease control OngoingThis study is testing whether a 6-session program called START helps families access ADHD treatments more easily. Researchers are comparing START against basic ADHD information pamphlets in 106 children aged 6-12 who are newly diagnosed or untreated. The goal is to see if START i…
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Apr 01, 2026 23:25 UTC
-
New program aims to unite parents and teachers to tackle preschool behavior issues
Disease control ENROLLING_BY_INVITATIONThis study is testing a new program called PEAR, designed to help parents and teachers work together more effectively. It focuses on improving the use of a proven classroom behavior system for children showing ADHD or disruptive behavior symptoms. The goal is to see if better tea…
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Can kids with chronic throat disease take less medicine?
Disease control OngoingThis study is testing whether children with a chronic inflammatory condition of the esophagus (Eosinophilic Esophagitis) can stay in remission using half their usual steroid dose. It aims to see if this lower dose is enough to control the disease while potentially reducing the ri…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Can a shingles shot protect vulnerable transplant patients?
Prevention ENROLLING_BY_INVITATIONThis study is testing the safety and effectiveness of the shingles vaccine in young adults who have received a solid organ transplant, like a heart, liver, or kidney. Participants will receive two doses of the vaccine and be closely monitored for side effects and their immune res…
Phase: PHASE4 • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Apr 01, 2026 23:26 UTC
-
Blood test breakthrough could replace scans for NF1 tumor tracking
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to find signals in the blood that can tell doctors about tumor growth in people with Neurofibromatosis type 1 (NF1). Researchers will study 200 people with NF1, using blood tests and full-body MRI scans to see if specific blood markers match the size and number of…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC